Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark F McCarty

Showing results (81-90 of 193) with videos related to

Pageof 20
Sort By:
Medical Hypotheses|November 29, 2005
Induction of heat shock proteins may combat insulin resistanceMark F McCarty
Healthcare (Basel, Switzerland)|July 16, 2016
Asymmetric Dimethylarginine Is a Well Established Mediating Risk Factor for Cardiovascular Morbidity and Mortality-Should Patients with Elevated Levels Be Supplemented with Citrulline?Mark F McCarty
Healthcare (Basel, Switzerland)|July 16, 2016
NADPH Oxidase Activity in Cerebral Arterioles Is a Key Mediator of Cerebral Small Vessel Disease-Implications for PreventionMark F McCarty
Medical Hypotheses|September 27, 2002
Glucomannan minimizes the postprandial insulin surge: a potential adjuvant for hepatothermic therapyMark F McCarty
Medical Hypotheses|September 27, 2002
Pre-exercise administration of yohimbine may enhance the efficacy of exercise training as a fat loss strategy by boosting lipolysisMark F McCarty
Medical Hypotheses|August 25, 2004
Vascular endothelium is the organ chiefly responsible for the catabolism of plasma asymmetric dimethylarginine--an explanation for the elevation of plasma ADMA in disorders characterized by endothelial dysfunctionMark F McCarty
Medical Hypotheses|July 9, 2004
Chronic activation of AMP-activated kinase as a strategy for slowing agingMark F McCarty
Medical Hypotheses|July 9, 2004
Does bitter melon contain an activator of AMP-activated kinase?Mark F McCarty
Medical Hypotheses|January 22, 2010
Potential utility of full-spectrum antioxidant therapy, citrulline, and dietary nitrate in the management of sickle cell diseaseMark F McCarty
Medical Hypotheses|December 2, 2011
Metformin may antagonize Lin28 and/or Lin28B activity, thereby boosting let-7 levels and antagonizing cancer progressionMark F McCarty
Pageof 20

Showing results (81-90 of 193) with videos related to

Sort By:
Pageof 20
Medical Hypotheses|November 29, 2005
Induction of heat shock proteins may combat insulin resistanceMark F McCarty
Healthcare (Basel, Switzerland)|July 16, 2016
Asymmetric Dimethylarginine Is a Well Established Mediating Risk Factor for Cardiovascular Morbidity and Mortality-Should Patients with Elevated Levels Be Supplemented with Citrulline?Mark F McCarty
Healthcare (Basel, Switzerland)|July 16, 2016
NADPH Oxidase Activity in Cerebral Arterioles Is a Key Mediator of Cerebral Small Vessel Disease-Implications for PreventionMark F McCarty
Medical Hypotheses|September 27, 2002
Glucomannan minimizes the postprandial insulin surge: a potential adjuvant for hepatothermic therapyMark F McCarty
Medical Hypotheses|September 27, 2002
Pre-exercise administration of yohimbine may enhance the efficacy of exercise training as a fat loss strategy by boosting lipolysisMark F McCarty
Medical Hypotheses|August 25, 2004
Vascular endothelium is the organ chiefly responsible for the catabolism of plasma asymmetric dimethylarginine--an explanation for the elevation of plasma ADMA in disorders characterized by endothelial dysfunctionMark F McCarty
Medical Hypotheses|July 9, 2004
Chronic activation of AMP-activated kinase as a strategy for slowing agingMark F McCarty
Medical Hypotheses|July 9, 2004
Does bitter melon contain an activator of AMP-activated kinase?Mark F McCarty
Medical Hypotheses|January 22, 2010
Potential utility of full-spectrum antioxidant therapy, citrulline, and dietary nitrate in the management of sickle cell diseaseMark F McCarty
Medical Hypotheses|December 2, 2011
Metformin may antagonize Lin28 and/or Lin28B activity, thereby boosting let-7 levels and antagonizing cancer progressionMark F McCarty
Pageof 20